Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
Partial hydatidiform mole progression into invasive mole with lung metastasis following in vitro fertilization.

Oncology letters

Zhou X, Chen Y, Li Y, Duan Z.
PMID: 22740971
Oncol Lett. 2012 Mar;3(3):659-661. doi: 10.3892/ol.2011.542. Epub 2011 Dec 28.

In the present study, the case of a 34-year-old Chinese female who underwent in vitro fertilization resulting in a twin pregnancy was reported. Following in vitro fertilization, the patient was found to have a partial hydatidiform mole (PHM) with...

Cite
Zhou X, Chen Y, Li Y, et al. Partial hydatidiform mole progression into invasive mole with lung metastasis following in vitro fertilization. Oncol Lett. 2011;3(3):659-661doi: 10.3892/ol.2011.542.
Zhou, X., Chen, Y., Li, Y., & Duan, Z. (2012). Partial hydatidiform mole progression into invasive mole with lung metastasis following in vitro fertilization. Oncology letters, 3(3), 659-661. https://doi.org/10.3892/ol.2011.542
Zhou, Xi, et al. "Partial hydatidiform mole progression into invasive mole with lung metastasis following in vitro fertilization." Oncology letters vol. 3,3 (2012): 659-661. doi: https://doi.org/10.3892/ol.2011.542
Zhou X, Chen Y, Li Y, Duan Z. Partial hydatidiform mole progression into invasive mole with lung metastasis following in vitro fertilization. Oncol Lett. 2012 Mar;3(3):659-661. doi: 10.3892/ol.2011.542. Epub 2011 Dec 28. PMID: 22740971; PMCID: PMC3362542.
Copy Download .nbib Format: NLM
Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation.

Pediatric blood & cancer

Terry W, Carlisle EM, Mallinger P, Nelson AT, Gordon D, Messinger YH, Field A, Dehner LP, Hill DA, Schultz KAP.
PMID: 34398502
Pediatr Blood Cancer. 2021 Nov;68(11):e29284. doi: 10.1002/pbc.29284. Epub 2021 Aug 16.

A 2-year-old boy presented with a large cystic and solid chest mass arising from the lung, radiographically consistent with pleuropulmonary blastoma (PPB). He underwent right lower lobectomy with resection of a well-circumscribed, mixed solid and cystic mass. The solid...

Cite
Terry W, Carlisle EM, Mallinger P, et al. Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatr Blood Cancer. 2021;68(11):e29284doi: 10.1002/pbc.29284.
Terry, W., Carlisle, E. M., Mallinger, P., Nelson, A. T., Gordon, D., Messinger, Y. H., Field, A., Dehner, L. P., Hill, D. A., & Schultz, K. A. P. (2021). Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatric blood & cancer, 68(11), e29284. https://doi.org/10.1002/pbc.29284
Terry, William, et al. "Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation." Pediatric blood & cancer vol. 68,11 (2021): e29284. doi: https://doi.org/10.1002/pbc.29284
Terry W, Carlisle EM, Mallinger P, Nelson AT, Gordon D, Messinger YH, Field A, Dehner LP, Hill DA, Schultz KAP. Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatr Blood Cancer. 2021 Nov;68(11):e29284. doi: 10.1002/pbc.29284. Epub 2021 Aug 16. PMID: 34398502; PMCID: PMC8463509.
Copy Download .nbib Format: NLM
Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation.

Pediatric blood & cancer

Terry W, Carlisle EM, Mallinger P, Nelson AT, Gordon D, Messinger YH, Field A, Dehner LP, Hill DA, Schultz KAP.
PMID: 34398502
Pediatr Blood Cancer. 2021 Nov;68(11):e29284. doi: 10.1002/pbc.29284. Epub 2021 Aug 16.

A 2-year-old boy presented with a large cystic and solid chest mass arising from the lung, radiographically consistent with pleuropulmonary blastoma (PPB). He underwent right lower lobectomy with resection of a well-circumscribed, mixed solid and cystic mass. The solid...

Cite
Terry W, Carlisle EM, Mallinger P, et al. Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatr Blood Cancer. 2021;68(11):e29284doi: 10.1002/pbc.29284.
Terry, W., Carlisle, E. M., Mallinger, P., Nelson, A. T., Gordon, D., Messinger, Y. H., Field, A., Dehner, L. P., Hill, D. A., & Schultz, K. A. P. (2021). Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatric blood & cancer, 68(11), e29284. https://doi.org/10.1002/pbc.29284
Terry, William, et al. "Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation." Pediatric blood & cancer vol. 68,11 (2021): e29284. doi: https://doi.org/10.1002/pbc.29284
Terry W, Carlisle EM, Mallinger P, Nelson AT, Gordon D, Messinger YH, Field A, Dehner LP, Hill DA, Schultz KAP. Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. Pediatr Blood Cancer. 2021 Nov;68(11):e29284. doi: 10.1002/pbc.29284. Epub 2021 Aug 16. PMID: 34398502; PMCID: PMC8463509.
Copy Download .nbib Format: NLM
Results of isolated limb perfusion for metastasized malignant melanoma.

Surgical oncology

Schellerer VS, Frenger J, Merkel S, Goehl J, Kersting S, Gruetzmann R, Erdmann M, Foertsch T.
PMID: 33992896
Surg Oncol. 2021 Sep;38:101603. doi: 10.1016/j.suronc.2021.101603. Epub 2021 May 08.

BACKGROUND AND OBJECTIVES: Locoregional metastases are typical biological manifestations of advanced malignant melanomas. Treatment with hyperthermic isolated limb perfusion (HILP) should be considered in affected patients. In the present study, we have analyzed the results of HILPs performed in...

Cite
Schellerer VS, Frenger J, Merkel S, et al. Results of isolated limb perfusion for metastasized malignant melanoma. Surg Oncol. 2021;38:101603doi: 10.1016/j.suronc.2021.101603.
Schellerer, V. S., Frenger, J., Merkel, S., Goehl, J., Kersting, S., Gruetzmann, R., Erdmann, M., & Foertsch, T. (2021). Results of isolated limb perfusion for metastasized malignant melanoma. Surgical oncology, 38101603. https://doi.org/10.1016/j.suronc.2021.101603
Schellerer, Vera S, et al. "Results of isolated limb perfusion for metastasized malignant melanoma." Surgical oncology vol. 38 (2021): 101603. doi: https://doi.org/10.1016/j.suronc.2021.101603
Schellerer VS, Frenger J, Merkel S, Goehl J, Kersting S, Gruetzmann R, Erdmann M, Foertsch T. Results of isolated limb perfusion for metastasized malignant melanoma. Surg Oncol. 2021 Sep;38:101603. doi: 10.1016/j.suronc.2021.101603. Epub 2021 May 08. PMID: 33992896.
Copy Download .nbib Format: NLM
Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis.

Journal of chemotherapy (Florence, Italy)

Hua Q, Xu G, Zhao L, Zhang T.
PMID: 33501892
J Chemother. 2021 Sep;33(5):319-327. doi: 10.1080/1120009X.2021.1873631. Epub 2021 Jan 27.

The objective of this study is to assess the effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma (STS) and provide a relative ranking of regimens for STS. We pooled the hazard ratios of overall survival (OS) and relapse...

Cite
Hua Q, Xu G, Zhao L, et al. Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. J Chemother. 2021;33(5):319-327doi: 10.1080/1120009X.2021.1873631.
Hua, Q., Xu, G., Zhao, L., & Zhang, T. (2021). Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. Journal of chemotherapy (Florence, Italy), 33(5), 319-327. https://doi.org/10.1080/1120009X.2021.1873631
Hua, Qingling, et al. "Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis." Journal of chemotherapy (Florence, Italy) vol. 33,5 (2021): 319-327. doi: https://doi.org/10.1080/1120009X.2021.1873631
Hua Q, Xu G, Zhao L, Zhang T. Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. J Chemother. 2021 Sep;33(5):319-327. doi: 10.1080/1120009X.2021.1873631. Epub 2021 Jan 27. PMID: 33501892.
Copy Download .nbib Format: NLM
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.

Cancer

Russell HV, Chi YY, Okcu MF, Bernhardt MB, Rodriguez-Galindo C, Gupta AA, Hawkins DS.
PMID: 34623638
Cancer. 2022 Jan 15;128(2):317-325. doi: 10.1002/cncr.33917. Epub 2021 Oct 08.

BACKGROUND: The Children's Oncology Group clinical trial for intermediate risk rhabdomyosarcoma randomized participants to a combination of vincristine, dactinomycin, and cyclophosphamide (VAC) alone or VAC alternating with vincristine plus irinotecan (VAC/VI). Clinical outcomes were similar, but toxicity profiles differed....

Cite
Russell HV, Chi YY, Okcu MF, et al. Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2021;128(2):317-325doi: 10.1002/cncr.33917.
Russell, H. V., Chi, Y. Y., Okcu, M. F., Bernhardt, M. B., Rodriguez-Galindo, C., Gupta, A. A., & Hawkins, D. S. (2022). Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer, 128(2), 317-325. https://doi.org/10.1002/cncr.33917
Russell, Heidi V, et al. "Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group." Cancer vol. 128,2 (2022): 317-325. doi: https://doi.org/10.1002/cncr.33917
Russell HV, Chi YY, Okcu MF, Bernhardt MB, Rodriguez-Galindo C, Gupta AA, Hawkins DS. Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2022 Jan 15;128(2):317-325. doi: 10.1002/cncr.33917. Epub 2021 Oct 08. PMID: 34623638.
Copy Download .nbib Format: NLM
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.

Cell discovery

Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F.
PMID: 32194980
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. Drug repurposing, representing...

Cite
Zhou Y, Hou Y, Shen J, et al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14doi: 10.1038/s41421-020-0153-3.
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell discovery, 614. https://doi.org/10.1038/s41421-020-0153-3
Zhou, Yadi, et al. "Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2." Cell discovery vol. 6 (2020): 14. doi: https://doi.org/10.1038/s41421-020-0153-3
Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020. PMID: 32194980; PMCID: PMC7073332.
Copy Download .nbib Format: NLM
Ewing's sarcoma of the mandible.

National journal of maxillofacial surgery

Rao BH, Rai G, Hassan S, Nadaf A.
PMID: 22639511
Natl J Maxillofac Surg. 2011 Jul;2(2):184-8. doi: 10.4103/0975-5950.94479.

Ewing's sarcoma is a malignant tumor of bones that primarily affects children and young adults. The true origin of this small round cell lesion still remains controversial. It was originally described by James Ewing in 1921 as arising from...

Cite
Rao BH, Rai G, Hassan S, et al. Ewing's sarcoma of the mandible. Natl J Maxillofac Surg. 2011;2(2):184-8doi: 10.4103/0975-5950.94479.
Rao, B. H., Rai, G., Hassan, S., & Nadaf, A. (2011). Ewing's sarcoma of the mandible. National journal of maxillofacial surgery, 2(2), 184-8. https://doi.org/10.4103/0975-5950.94479
Rao, B H Sripathi, et al. "Ewing's sarcoma of the mandible." National journal of maxillofacial surgery vol. 2,2 (2011): 184-8. doi: https://doi.org/10.4103/0975-5950.94479
Rao BH, Rai G, Hassan S, Nadaf A. Ewing's sarcoma of the mandible. Natl J Maxillofac Surg. 2011 Jul;2(2):184-8. doi: 10.4103/0975-5950.94479. PMID: 22639511; PMCID: PMC3343390.
Copy Download .nbib Format: NLM
Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid.

Rare tumors

Natale R, Thariat J, Vedrine PO, Bozec A, Peyrottes I, Marcy PY, Haudebourg J, Pedeutour F, Saâda E, Thyss A.
PMID: 23888220
Rare Tumors. 2013 May 29;5(2):75-8. doi: 10.4081/rt.2013.e20. Print 2013 Apr 15.

Primitive neuroectodermal tumors (PNET) represent 1% of sarcomas. Head and neck peripheral PNETs have an intermediate prognosis between abdominopelvic disease and extremities. We here report the case of a 40-year old male who presented with primitive neuroectodermal tumor of...

Cite
Natale R, Thariat J, Vedrine PO, et al. Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid. Rare Tumors. 2013;5(2):75-8doi: 10.4081/rt.2013.e20.
Natale, R., Thariat, J., Vedrine, P. O., Bozec, A., Peyrottes, I., Marcy, P. Y., Haudebourg, J., Pedeutour, F., Saâda, E., & Thyss, A. (2013). Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid. Rare tumors, 5(2), 75-8. https://doi.org/10.4081/rt.2013.e20
Natale, Romain, et al. "Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid." Rare tumors vol. 5,2 (2013): 75-8. doi: https://doi.org/10.4081/rt.2013.e20
Natale R, Thariat J, Vedrine PO, Bozec A, Peyrottes I, Marcy PY, Haudebourg J, Pedeutour F, Saâda E, Thyss A. Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid. Rare Tumors. 2013 May 29;5(2):75-8. doi: 10.4081/rt.2013.e20. Print 2013 Apr 15. PMID: 23888220; PMCID: PMC3719115.
Copy Download .nbib Format: NLM
The coexistence of a Wilms' tumor and renal cell carcinoma in children: a case report and review of the literature.

OncoTargets and therapy

Zou XP, Jiang YY, Liao Y, Dang YW, Chen G, Feng ZB, Ma Y.
PMID: 30774381
Onco Targets Ther. 2019 Jan 30;12:953-958. doi: 10.2147/OTT.S186102. eCollection 2019.

A combination of a Wilms' tumor (WT) and renal cell carcinoma (RCC) is an extremely rare pediatric renal neoplasm. Its prognosis and clinicopathological features remain unclarified. Herein, we describe a case of the coexistence of a WT and an...

Cite
Zou XP, Jiang YY, Liao Y, et al. The coexistence of a Wilms' tumor and renal cell carcinoma in children: a case report and review of the literature. Onco Targets Ther. 2019;12:953-958doi: 10.2147/OTT.S186102.
Zou, X. P., Jiang, Y. Y., Liao, Y., Dang, Y. W., Chen, G., Feng, Z. B., & Ma, Y. (2019). The coexistence of a Wilms' tumor and renal cell carcinoma in children: a case report and review of the literature. OncoTargets and therapy, 12953-958. https://doi.org/10.2147/OTT.S186102
Zou, Xiao-Ping, et al. "The coexistence of a Wilms' tumor and renal cell carcinoma in children: a case report and review of the literature." OncoTargets and therapy vol. 12 (2019): 953-958. doi: https://doi.org/10.2147/OTT.S186102
Zou XP, Jiang YY, Liao Y, Dang YW, Chen G, Feng ZB, Ma Y. The coexistence of a Wilms' tumor and renal cell carcinoma in children: a case report and review of the literature. Onco Targets Ther. 2019 Jan 30;12:953-958. doi: 10.2147/OTT.S186102. eCollection 2019. PMID: 30774381; PMCID: PMC6361228.
Copy Download .nbib Format: NLM
Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman.

Gynecologic oncology reports

Gwacham NI, Van Brunt L, Ernst Y, Gibbon D.
PMID: 31245524
Gynecol Oncol Rep. 2019 Jun 13;29:29-33. doi: 10.1016/j.gore.2019.06.002. eCollection 2019 Aug.

Gestational trophoblastic neoplasia (GTN) with brain metastasis is usually seen in patients with advanced disease. Ten percent of metastatic gestational trophoblastic disease involves the brain and spinal cord, most often manifesting as an intracerebral mass or subdural hematoma, and...

Cite
Gwacham NI, Van Brunt L, Ernst Y, et al. Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman. Gynecol Oncol Rep. 2019;29:29-33doi: 10.1016/j.gore.2019.06.002.
Gwacham, N. I., Van Brunt, L., Ernst, Y., & Gibbon, D. (2019). Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman. Gynecologic oncology reports, 2929-33. https://doi.org/10.1016/j.gore.2019.06.002
Gwacham, Nnamdi I, et al. "Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman." Gynecologic oncology reports vol. 29 (2019): 29-33. doi: https://doi.org/10.1016/j.gore.2019.06.002
Gwacham NI, Van Brunt L, Ernst Y, Gibbon D. Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman. Gynecol Oncol Rep. 2019 Jun 13;29:29-33. doi: 10.1016/j.gore.2019.06.002. eCollection 2019 Aug. PMID: 31245524; PMCID: PMC6582189.
Copy Download .nbib Format: NLM
Biological Drivers of Wilms Tumor Prognosis and Treatment.

Children (Basel, Switzerland)

Phelps HM, Kaviany S, Borinstein SC, Lovvorn HN.
PMID: 30373137
Children (Basel). 2018 Oct 26;5(11). doi: 10.3390/children5110145.

Prior to the 1950s, survival from Wilms tumor (WT) was less than 10%. Today, a child diagnosed with WT has a greater than 90% chance of survival. These gains in survival rates from WT are attributed largely to improvements...

Cite
Phelps HM, Kaviany S, Borinstein SC, et al. Biological Drivers of Wilms Tumor Prognosis and Treatment. Children (Basel). 2018;5(11)doi: 10.3390/children5110145.
Phelps, H. M., Kaviany, S., Borinstein, S. C., & Lovvorn, H. N. (2018). Biological Drivers of Wilms Tumor Prognosis and Treatment. Children (Basel, Switzerland), 5(11), . https://doi.org/10.3390/children5110145
Phelps, Hannah M, et al. "Biological Drivers of Wilms Tumor Prognosis and Treatment." Children (Basel, Switzerland) vol. 5,11 (2018). doi: https://doi.org/10.3390/children5110145
Phelps HM, Kaviany S, Borinstein SC, Lovvorn HN. Biological Drivers of Wilms Tumor Prognosis and Treatment. Children (Basel). 2018 Oct 26;5(11). doi: 10.3390/children5110145. PMID: 30373137; PMCID: PMC6262554.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries